Novartis AG (NVS) annual results, year to 31 December 2018: revenue USD 44,833 million, from the 20-F
Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2018 it reported revenue from the sale of goods of USD 44,833 million, up 5.8% on the year before. Its profit attributable to shareholders was USD 12,611 million, up 63.7%, and diluted earnings per share USD 5.38.
this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.
Income statement (profit and loss)
| Year to | Dec 2017 † | Dec 2018 † |
|---|---|---|
| Revenue from the sale of goods | 42,381 | 44,833 |
| Cost of sales | 13,633 | 14,510 |
| Gross profit | 29,771 | 31,589 |
| Research and development | 8,389 | 8,489 |
| Selling, general and administrative | 12,465 | 13,717 |
| Operating profit | 8,702 | 8,403 |
| Profit before tax | 9,102 | 14,095 |
| Income tax | 1,603 | 1,295 |
| Profit for the year | 7,703 | 12,614 |
| Profit attributable to shareholders | 7,703 | 12,611 |
| Filing | 20-F | 20-F |
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read more
A line the company does not file under the standard tag is left out rather than estimated.USD per ordinary share, as filed.
Cash flow
| Year to | Dec 2017 † | Dec 2018 † |
|---|---|---|
| Cash from operations | 12,621 | 14,272 |
| Purchase of property, plant and equipment | 1,325 | 1,254 |
| Free cash flow | 11,296 | 13,018 |
| Cash from investing | -3,119 | -5,591 |
| Cash from financing | -7,733 | -4,244 |
| Buybacks | 5,490 | 2,036 |
| Dividends paid | 6,495 | 6,966 |
| Filing | 20-F | 20-F |
USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.
Balance sheet
| Year to | Dec 2017 † | Dec 2018 † |
|---|---|---|
| Funded by | ||
| Equity attributable to shareholders | 74,168 | 78,614 |
| Non-controlling interests | 59.0 | 78.0 |
| Borrowings, as filed | 23,583 | 25,660 |
| Other liabilities | 35,269 | 41,211 |
| Total equity and liabilities | 133,079 | 145,563 |
| Owned | ||
| Property, plant and equipment | 16,464 | 15,696 |
| Goodwill | 31,750 | 35,294 |
| Other intangible assets | 29,997 | 38,719 |
| Cash and cash equivalents | 8,860 | 13,271 |
| Inventories | 6,867 | 6,956 |
| Other assets | 39,141 | 35,627 |
| Total assets | 133,079 | 145,563 |
| Filing | 20-F | 20-F |
USD million, at each fiscal year end.
Ratios on the filed lines
| Year to | Dec 2017 † | Dec 2018 † |
|---|---|---|
| Return on year-end equity | 10.4% | 16.0% |
| Effective tax rate | 17.6% | 9.2% |
| Filing | 20-F | 20-F |
Arithmetic on the filed lines of the same year.
20-F for the year to 31 December 2018, filed 26 January 2021: the filing. The figures are in US dollars as filed.